Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Once-weekly dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes
In this video, well cover: - **Overview of the Medications**: Learn about the mechanism of action
By mimicking GLP-1, Tirzepatide convinces the body that it is more satisfied than it might actually be, subduing those persistent hunger cravings
The most frequently reported side effects were gastrointestinal in nature, including nausea (occurring in 25-33% of patients depending on dose), diarrhea (21-23%), and vomiting (8-10%)
US$ 29.85
US$ 21.15
US$ 25.41
US$ 26.71
